A pharmaceutical industry trade group is suing Minnesota in an effort to block a new state law that provides free emergency insulin to patients who can’t afford it.
The Pharmaceutical Research and Manufacturers of America alleges that the law is unconstitutional because it would take drugmakers’ private property for public use without just compensation, according to a complaint filed Tuesday in the U.S. District Court for the District of Minnesota.
The lawsuit comes amid an ongoing debate over rising drug prices, particularly for insulin, a medication necessary to survival for more than 7 million Americans.
The group claims the law, ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.